Global Nuclear Imaging Devices Market Size, Trends, and Growth Opportunity, By Product (Hybrid Pet, Single Photon-Emission Computed Tomography (SPECT), Planar Scintigraphy), Application (Neurology, Oncology, Cardiology, Others), End User (Academic and Research Centers, Hospitals, Imaging Centers, Others) By Region and forecast till 2030.
Global Nuclear Imaging Devices Market
Global Nuclear Imaging Devices Market was valued at USD 2.94 Billion in 2022 and is slated to reach USD 4.63 Billion by 2030 at a CAGR of 5.84 % from 2023-2030.
To assess the severity of illnesses including cancer, endocrine, gastrointestinal, cardiovascular, neurological, and other brain problems, nuclear imaging devices are the types of medical imaging equipment frequently utilized with radioactive materials. Clinicians can diagnose and assess medical issues thanks to these non-invasive technologies, which provide operational data at the molecular and cellular levels. PET systems, SPECT systems, and planar scintigraphy are the three main product types in nuclear imaging devices and equipment.
Market Drivers
Rising rates of breast cancer, which are fueling faster market expansion. Breast Cancer Information Sheet As of 2021, every year in the UK, 370 men and 55,000 women are given a breast cancer diagnosis. An estimated 600,000 persons in the UK have died as a result of breast cancer. Nuclear imaging technologies, which aid in the proper detection of the devices, are increasingly adopted as incidence rises. This element stimulates market expansion. Market expansion was a result of technological developments. These systems for multimodality imaging include SPECT/CT, PET/CT, PET/MRI, and PET/SPECT/CT. For instance, in 2022, Spectrum Dynamics will introduce its most recent advancement in wide-bore, 3600-CZT-based SPECT/CT imaging technology, which will enable the imaging of high-energy isotopes. Positive market growth effects are anticipated as a result.
Market Restraints
Strict guidelines set forth by the Nuclear Regulatory Commission (NRC) for medical use place restrictions on the market for nuclear imaging systems and equipment. For example, the NRC mandates that license holders of nuclear imaging equipment utilize and store radioactive materials to protect workers and the public by preventing unintentional exposure, which results in the production of comparatively few nuclear imaging types of equipment. The market expansion is thus hampered by these issues.
Impact of COVID-19
The global supply of hospital resources has been considerably impacted by the COVID-19 pandemic. This has mostly been controlled by drastically cutting back on in-patient and out-patient services for other illnesses and putting in place infection prevention and control measures. Nuclear medicine treatments for both diagnostic and therapeutic purposes sharply decreased as the epidemic spread to several nations. The majority of nuclear medicine scans and treatments are performed in outpatient clinics as follow-up cases, although new studies are often managed in inpatient clinics following COVID-19 screening. Due to the lack of portable SPECT and PET scanners, radiopharmaceuticals must constantly be injected into patients in nuclear medicine to allow for unrestricted movement. Therefore, nuclear medical personnel needs to possess an in-depth understanding of safety precautions to prevent Covid-19 transmission. The majority of heart patients undergoing nuclear cardiology treatments are often older than 60 and have other serious health risks such as diabetes, hypertension, chronic renal and lung disorders, and obesity. They are extremely susceptible to developing COVID-19 as a result of all of these circumstances, which has decreased the demand for nuclear imaging treatments.
Recent Developments
In October 2022, United Imaging Healthcare announced the availability of explorer, a total-body PET/CT with a 194 cm axial field of view (FOV) that enables the entire body to be scanned in a one-bed configuration. Whole-body dynamic scanning is made possible by the ultra-high-resolution digital PET/CT system, which also offers ultra-high picture quality and ultra-low patient dose.
At the 35th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain, in October 2022, GE Healthcare debuted the Omni Legend positron emission tomography/computed tomography (PET/CT) platform.
Market Segmentation
Global Nuclear Imaging Devices Market is segmented By Application, By Product, and End User. By Products such as Hybrid Pet, Single Photon-Emission Computed Tomography (SPECT), and Planar Scintigraphy. By Applications such as Neurology, Oncology, Cardiology, and Others. By End Users such as Academic and Research Centers, Hospitals, Imaging Centers, and Others.
Regional Analysis
Global Nuclear Imaging Devices Market is segmented into five regions Americas, Europe, Asia-Pacific, and the Middle East & Africa. Because of the prevalence of significant market participants, North America dominates the market for nuclear imaging instruments. The prevalence of cancer and cardiovascular disease is also expected to rise, which will further boost the growth of the nuclear imaging devices market in the region for the forecast year. The increase in governmental and private investments in the expansion of medical infrastructure is predicted to cause Asia-Pacific to experience significant growth. Additionally, it is predicted that in the next years, the region's market for nuclear imaging devices will develop more rapidly due to the aging population.
Key Players
This report includes a list of numerous Key Players, namely SurgicEye GmbH (Germany), DIGIRAD CORPORATION (U.S.), Neusoft Corporation (China), Absolute Imaging Inc. (Canada), Bartec Technologies Ltd. (U.K.), CMR Naviscan. (U.S.), Koninklijke Philips N.V. (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), Spectrum Dynamics Medical (Switzerland), Ashby Gorman Baker Ltd. (Belgium).
Market Taxonomy
By Product
• Single Photon-Emission Computed Tomography (SPECT)
• Hybrid SPECT Systems
• Standalone SPECT Systems
• Hybrid Pet
• Planar Scintigraphy
By Application
• Oncology
• Cardiology
• Neurology
• Others
• Urology
• Orthopedics
• Gastroenterology
• Thyroid-Related Disorders
By End User
• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others
By Region
• North America Latin America
• Europe
• Asia Pacific
• Middle East & Africa.
Global Nuclear Imaging Devices Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Nuclear Imaging Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Nuclear Imaging Devices Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Nuclear Imaging Devices Market Share Analysis, By Product
5.3 Global Nuclear Imaging Devices Market Size and Forecast, By Product
5.3.1 Single Photon-Emission Computed Tomography (SPECT)
5.3.2 Hybrid SPECT Systems
5.3.3 Standalone SPECT Systems
5.3.4 Hybrid Pet
5.3.5 Planar Scintigraphy
6 Global Nuclear Imaging Devices Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Nuclear Imaging Devices Market Share Analysis, By Application
6.3 Global Nuclear Imaging Devices Market Size and Forecast, By Application
6.3.1 Oncology
6.3.2 Cardiology
6.3.3 Neurology
6.3.4 Others
6.3.5 Urology
6.3.6 Orthopedics
6.3.7 Gastroenterology
6.3.8 Thyroid-Related Disorders
7 Global Nuclear Imaging Devices Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Nuclear Imaging Devices Market Share Analysis, By End User
7.3 Global Nuclear Imaging Devices Market Size and Forecast, By End User
7.3.1 Hospitals
7.3.2 Imaging Centers
7.3.3 Academic and Research Centers
7.3.4 Others
8 Global Nuclear Imaging Devices Market, By Region
8.1 Global Nuclear Imaging Devices Market Share Analysis, By Region
8.2 Global Nuclear Imaging Devices Market Share Analysis, By Region
8.3 Global Nuclear Imaging Devices Market Size and Forecast, By Region
9 North America Nuclear Imaging Devices Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Nuclear Imaging Devices Market Share Analysis, By Product
9.3 North America Nuclear Imaging Devices Market Size and Forecast, By End User
9.4 North America Nuclear Imaging Devices Market Size and Forecast, By Application
9.5 North America Nuclear Imaging Devices Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeNuclear Imaging Devices Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Nuclear Imaging Devices Market Share Analysis, By Product
10.3 Europe Nuclear Imaging Devices Market Size and Forecast, By End User
10.4 Europe Nuclear Imaging Devices Market Size and Forecast, By Application
10.5 Europe Nuclear Imaging Devices Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Nuclear Imaging Devices Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Nuclear Imaging Devices Market Share Analysis, By Product
11.3 Asia Pacific Nuclear Imaging Devices Market Size and Forecast, By End User
11.4 Asia Pacific Nuclear Imaging Devices Market Size and Forecast, By Application
11.5 Asia Pacific Nuclear Imaging Devices Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Nuclear Imaging Devices Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Nuclear Imaging Devices Market Share Analysis, By Product
12.3 Latin America Nuclear Imaging Devices Market Size and Forecast, By End User
12.4 Latin America Nuclear Imaging Devices Market Size and Forecast, By Application
12.5 Latin America Nuclear Imaging Devices Market Size and Forecast, Country
12.5.1. Brazil
12.5.2.Rest of Latin America
13 Middle East Nuclear Imaging Devices Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Nuclear Imaging Devices Market Share Analysis, By Product
13.3 Middle East Nuclear Imaging Devices Market Size and Forecast, By End User
13.4 Middle East Nuclear Imaging Devices Market Size and Forecast, By Application
13.5 Middle East Nuclear Imaging Devices Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 SurgicEye GmbH (Germany)
15.1.1 Overview
15.1.2 Products
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. DIGIRAD CORPORATION (U.S.)
15.2.1 Overview
15.2.2 Products
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
12.2.6 Key Strategies
15.3. Neusoft Corporation (China)
15.3.1 Overview
15.3.2 Products
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Absolute Imaging Inc. (Canada)
15.4.1 Overview
15.4.2 Products
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Bartec Technologies Ltd. (U.K.)
15.5.1 Overview
15.5.2 Products
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 CMR Naviscan. (U.S.)
15.6.1 Overview
15.6.2 Products
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Koninklijke Philips N.V. (Netherlands)
15.7.1 Overview
15.7.2 Products
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 CANON MEDICAL SYSTEMS CORPORATION (Japan)
15.8.1 Overview
15.8.2 Products
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Spectrum Dynamics Medical (Switzerland)
15.9.1 Overview
15.9.2 Products
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Ashby Gorman Baker Ltd. (Belgium)
15.10.1 Overview
15.10.2 Products
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
